CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services

jump over right navigation bar
TB Notes 4, 2006
Director's Letter
Highlights from State and Local Programs
  Los Angeles Presents "The Opera and Perspectives on TB"
  Arizona's and Sonora's Meet and Greet Program for Deportees with TB
  The Flex Power of Memoranda of Agreements (MOAs)
  HIV Status Not Routinely Determined for TB Cases: an Evaluation of Four California Local TB Programs
CDC/ATSDR Group Award for Minority Health Mentor/Champion of Excellence
Laboratory Update
  New Technologies Unveiled at the 2006 National TB Controllers' Workshop
Nursing Updates
  The Red Snappers of National Tuberculosis Nurses Coalition (NTNC)
  Pacific Island TB Controllers Association (PITCA) -  Workshop for Nurses
TB Education and Training Network Updates
  Member Highlight
  Sixth Annual Conference Highlights
  Cultural Competency Subcommittee Update
Communication, Education, and Behavioral Studies Branch Update
  New Communication Efforts to Stop TB in the African-American Community
Clinical and Health Systems Research Branch Update
  Using a Private Claims Database for TB Health Services Research, Evaluation, and Analysis
Surveillance, Epidemiology, and Outbreak Investigations Branch Updates
  9th Semiannual Meeting of the Tuberculosis Epidemiologic Studies Consortium
  TBESC Task Order #10: Monitoring Performance and Measuring Cost of TB Public Health Practice at County and State Health Departments: Are We Making a Health Impact?
New CDC Publications
Personnel Notes
Calendar of Events
Return to Table of Contents

TB Notes Newsletter

No. 4, 2006

New CDC Publications

Andre MD, Ijaz K, Tillinghast JD, Krebs VE, Diem LA, Metchock B, Crisp T, and McElroy PD. Transmission network analysis to complement routine tuberculosis contact investigations. Am J Public Health Nov. 2006; 96 (11):1-8.

Burman WJ, Goldberg S, Johnson JL, Muzanye G, Engle M, Mosher AW, Choudhri S, Daley CL, Munsiff SS, Zhao Z, Vernon A, Chaisson RE, and the Tuberculosis Trials Consortium. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174:331-338.

Butler WR, Floyd MM, Brown JM, Toney SR, Daneshvar MI, Cooksey RC, Carr J, Steigerwalt AG, Charles N. Novel mycolic acid–containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., with descriptions of Segniliparus rotundus sp. nov. and Segniliparus rugosus sp. nov. International Journal of Systematic and Evolutionary Microbiology 2005; 55: 1615-1624.

CDC. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. MMWR July 2006; 55 (RR-9).

Holtz TH, Lancaster J, Laserson KF, Wells CD, Thorpe L, Weyer K. Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999–2001. Int J Tuberc Lung Dis June 2006; 10(6):649-655.

Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR, and the Tuberculosis Trials Consortium. Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med 2006; 174:344-348.

Lofy KH, McElroy PD, Lake L, Cowan LS, Diem LA, Goldberg SV, Cangelosi GA, Tribble SP, Cave MD, Narita M. Outbreak of tuberculosis in a homeless population involving multiple sites of transmission. Int J Tuberc Lung Dis June 2006; 10(6):683-689.

Macaraig M, Agerton T, Driver CR, Munsiff SS, Abdelwahab J, Park J, Kreiswirth B, Driscoll J, and Zhao B. Strain-specific differences in two large Mycobacterium tuberculosis genotype clusters in isolates collected from homeless patients in New York City from 2001 to 2004.  Journal of Clinical Microbiology 2006 Aug; 44(8): 2890-6.

Manangan LP, Moore M, Macaraig M, MacNeil J, Shevick G, Northrup J, Pratt R, Adams LV, Boutotte J, Sharnprapai S, Qualls N. Health department costs of managing persons with suspected and noncounted tuberculosis in New York City, three Texas counties, and Massachusetts. J Public Health Management and Practice 2006; 12(3): 248-253.

Moonan PK, Oppong J, Sahbazian B, Singh KP, Sandhu R, Drewyer G, Lafon T, Marruffo M, Quitugua TN, Wallace C, and Weis SE. What is the outcome of targeted tuberculosis screening based on universal genotyping and location? American Journal of Respiratory and Critical Care Medicine 2006 Sep 1; 174(5): 599-604.

Mugisha B, Bock N, Mermin J, Odeke RM, Miller B, Adatu-Engwau F, Granich R, Bunnell R. Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda. Int J Tuberc Lung Dis July 2006;10(7):761-767.

Munsiff SS, Ahuja SD, King L, Udeagu C-C, Dorsinville M, Frieden TR, Fujiwara PI. Ensuring accountability: the contribution of the cohort review method to tuberculosis control in New York City. Int J Tuberc Lung Dis 2006; 10(10): 1133-1139.

Munsiff SS, Ahuja SD, Li J, Driver CR. Public-private collaboration for multidrug-resistant tuberculosis control in New York City. Int J Tuberc Lung Dis June 2006; 10(6): 639-648.

Munsiff SS, Li J, Cook SV, Piatek A, Laraque F, Ebrahimzadeh A, and Fujiwara PI. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003. Clinical Infectious Diseases 2006 Jun 15; 42(12): 1702-10. Also Epub 2006 May 12.

Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis Sept 2006; 12(9):1389-1397. Also available from

Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Peloquin CA, Gordin FM, Nunes D, Strader DB, Bernardo J, Venkataramanan R, and Sterling TR. An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy. American Journal of Respiratory and Critical Care Medicine 2006 Oct 15; 174 (8):935-52.

Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Weiner M, Vernon A for the Tuberculosis Trials Consortium. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis May 2006; 10(5):542-549.

Yagui M, Perales MT, Asencios L, Vergara L, Suarez C, Yale G, Salazar C, Saavedra M, Shin S, Ferrousier O, Cegielski P. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis August 2006; 10(8):838-843.


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333